Dea Gorka

Dea Gorka is a Research Scientist at Arvinas, specializing in biomedical sciences with a focus on 15q imprinting disorders utilizing iPSCs and hESCs. Prior experience includes serving as a Graduate Research Fellow at The University of Connecticut School of Medicine, where research concentrated on genetic and cellular deficits in neurodevelopmental disorders, particularly Prader-Willi Syndrome and Angelman Syndrome. Gorka has also worked as a Venture Capital Fellow at Canaan, gaining insights into early-stage health care investments, and as an Undergraduate Research Fellow at the University of Connecticut, studying drug treatments for motivational dysfunctions in rodents. Additionally, an Undergraduate Summer Research Intern role at The University of Connecticut Health Center involved investigating CRISPR/Cas9 efficiency on iPSCs in the context of Prader-Willi Syndrome. Gorka holds a PhD in Biomedical Sciences from The University of Connecticut Health Center, along with a Bachelor of Science in Physiology and Neurobiology from the University of Connecticut.